Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 2
1953 2
1955 1
1956 1
1957 2
1958 3
1959 2
1960 2
1961 2
1962 5
1963 3
1964 5
1965 1
1969 1
1971 2
1972 1
1973 1
1975 3
1977 1
1978 5
1979 1
1980 4
1981 5
1982 8
1983 7
1984 6
1985 13
1986 16
1987 4
1988 22
1989 45
1990 40
1991 51
1992 41
1993 53
1994 59
1995 77
1996 44
1997 53
1998 74
1999 71
2000 85
2001 92
2002 88
2003 94
2004 89
2005 96
2006 94
2007 129
2008 139
2009 143
2010 147
2011 144
2012 171
2013 178
2014 160
2015 140
2016 170
2017 171
2018 165
2019 164
2020 214
2021 246
2022 263
2023 253
2024 238
2025 114

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,267 results

Results by year

Filters applied: . Clear all
Page 1
Eosinophilic granulomatosis with polyangiitis: A review.
White J, Dubey S. White J, et al. Autoimmun Rev. 2023 Jan;22(1):103219. doi: 10.1016/j.autrev.2022.103219. Epub 2022 Oct 22. Autoimmun Rev. 2023. PMID: 36283646 Free article. Review.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, multi-system, inflammatory disease, belonging to the group of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV). Previously known as Churg-Strauss …
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, multi-system, inflammatory disease, belonging to …
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.
Emmi G, Bettiol A, Gelain E, Bajema IM, Berti A, Burns S, Cid MC, Cohen Tervaert JW, Cottin V, Durante E, Holle JU, Mahr AD, Del Pero MM, Marvisi C, Mills J, Moiseev S, Moosig F, Mukhtyar C, Neumann T, Olivotto I, Salvarani C, Seeliger B, Sinico RA, Taillé C, Terrier B, Venhoff N, Bertsias G, Guillevin L, Jayne DRW, Vaglio A. Emmi G, et al. Nat Rev Rheumatol. 2023 Jun;19(6):378-393. doi: 10.1038/s41584-023-00958-w. Epub 2023 May 9. Nat Rev Rheumatol. 2023. PMID: 37161084 Review.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and granulomatous or vasculitic involvement of several organs. ...
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody (ANCA)-assoc …
Eosinophilic granulomatosis with polyangiitis.
Romero Gómez C, Hernández Negrín H, Ayala Gutiérrez MDM. Romero Gómez C, et al. Med Clin (Barc). 2023 Apr 6;160(7):310-317. doi: 10.1016/j.medcli.2023.01.003. Epub 2023 Feb 9. Med Clin (Barc). 2023. PMID: 36774291 Review. English, Spanish.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized by the presence of asthma associated with eosinophilia, eosinophilic infiltration of different organs, and vasculitis of small and medium-sized vessels. …
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized by the presence of a …
Eosinophilic granulomatosis with polyangiitis.
Villa-Forte A. Villa-Forte A. Postgrad Med. 2023 Jan;135(sup1):52-60. doi: 10.1080/00325481.2022.2134624. Epub 2022 Dec 5. Postgrad Med. 2023. PMID: 36259957 Review.
This review aims to describe the epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prognosis of eosinophilic granulomatosis with polyangiitis (EGPA). Eosinophilic granulomatosis with polyangiitis …
This review aims to describe the epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prognosis of eosinophilic …
Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management.
Trivioli G, Terrier B, Vaglio A. Trivioli G, et al. Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii84-iii94. doi: 10.1093/rheumatology/kez570. Rheumatology (Oxford). 2020. PMID: 32348510 Review.
Eosinophilic granulomatosis with polyangiitis is characterized by asthma, blood and tissue eosinophilia and small-vessel vasculitis. ...Eosinophilic granulomatosis with polyangiitis must be differentiated from several condit …
Eosinophilic granulomatosis with polyangiitis is characterized by asthma, blood and tissue eosinophilia and smal …
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis.
Bloom JL, Langford CA, Wechsler ME. Bloom JL, et al. Rheum Dis Clin North Am. 2023 Aug;49(3):563-584. doi: 10.1016/j.rdc.2023.03.006. Rheum Dis Clin North Am. 2023. PMID: 37331733 Review.
Eosinophilic granulomatosis with polyangiitis (EGPA) is an eosinophilic vasculitis that affects a variety of organ systems. ...
Eosinophilic granulomatosis with polyangiitis (EGPA) is an eosinophilic vasculitis that affects a variety …
Eosinophilic granulomatosis with polyangiitis: Cutaneous clinical and histopathologic differential diagnosis.
Tabb ES, Duncan LM, Nazarian RM. Tabb ES, et al. J Cutan Pathol. 2021 Nov;48(11):1379-1386. doi: 10.1111/cup.14065. Epub 2021 Jun 6. J Cutan Pathol. 2021. PMID: 34019312 Review.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, but severe systemic vasculitis that can affect skin and other organ systems. ...According to the EGPA Consensus Task Force recommendations, EGPA is a syndrome of asthma, eosinophili …
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, but severe systemic vasculitis that can affect s …
Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.
Wechsler ME, Hellmich B, Cid MC, Jayne D, Tian X, Baylis L, Roufosse F. Wechsler ME, et al. J Allergy Clin Immunol. 2023 Jun;151(6):1415-1428. doi: 10.1016/j.jaci.2023.03.011. Epub 2023 Apr 21. J Allergy Clin Immunol. 2023. PMID: 37086239 Free article. Review.
Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) are rare systemic inflammatory disorders with overlapping symptoms, elevated eosinophil counts, and heterogenous clinical presentations. ...
Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) are rare system …
Therapeutic advances in eosinophilic granulomatosis with polyangiitis.
Ford JA, Aleatany Y, Gewurz-Singer O. Ford JA, et al. Curr Opin Rheumatol. 2022 May 1;34(3):158-164. doi: 10.1097/BOR.0000000000000873. Epub 2022 Apr 18. Curr Opin Rheumatol. 2022. PMID: 35440531 Review.
PURPOSE OF REVIEW: In recent years, therapeutic advances in eosinophilic granulomatosis with polyangiitis (EGPA) have changed our treatment paradigm. ...
PURPOSE OF REVIEW: In recent years, therapeutic advances in eosinophilic granulomatosis with polyangiitis (EGPA) …
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L. Groh M, et al. Eur J Intern Med. 2015 Sep;26(7):545-53. doi: 10.1016/j.ejim.2015.04.022. Epub 2015 May 9. Eur J Intern Med. 2015. PMID: 25971154 Free article.
OBJECTIVE: To develop disease-specific recommendations for the diagnosis and management of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) (EGPA). METHODS: The EGPA Consensus Task Force experts comprised 8 pu …
OBJECTIVE: To develop disease-specific recommendations for the diagnosis and management of eosinophilic granulomatosis with …
4,267 results